The Bupropion Hydrochloride Tablets, cataloged under National Stock Number 6505-01-498-3167, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Glaxo Wellcome Inc. Government technical data includes 1 specification, cited from the U.S. Government catalog. The record lists 7 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-498-3167 |
| Primary Part Number | NDC00173-0135-55 |
| Item Name | Bupropion Hydrochloride Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Glaxo Wellcome Inc |
| Status | ACTIVE |
| American Hospital Formulary Service Classification Number | 281604 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC00591-3541-60 | Amerisourcebergen Drug Corp Dba Amerisourcebergen Drug Corp Div Corporate Office (USA) |
| NDC00185-0415-60 | Amerisourcebergen Drug Corp Dba Amerisourcebergen Drug Corp Div Corporate Office (USA) |
| NDC00173-0135-55 PRIMARY | Glaxo Wellcome Inc (USA) |
| NDC50228-0175-60 PRIMARY | Sciegen Pharmaceuticals Inc (USA) |
| NDC00173-0135-55 | Amerisourcebergen Drug Corp Dba Amerisourcebergen Drug Corp Div Corporate Office (USA) |
| NDC77771-0175-60 | Radha Pharmaceuticals Inc (USA) |
| NDC00185-0415-60 | Cardinal Health, Inc. (USA) |
| Reference | Meaning |
|---|---|
| WELLBUTRIN | 5/1 Secondary reference Glaxo Wellcome Inc |
| 02-0957 | 5/1 Secondary reference U.S. Government activity |
| NDC00591-3541-60 | 5/9 Secondary reference Actavis Pharma, Inc. |
NSN 6505-01-498-3167 is a Bupropion Hydrochloride Tablets, manufactured by Glaxo Wellcome Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-498-3167 has 7 manufacturer part numbers on file: NDC00591-3541-60 (Amerisourcebergen Drug Corp Dba Amerisourcebergen Drug Corp Div Corporate Office), NDC00185-0415-60 (Amerisourcebergen Drug Corp Dba Amerisourcebergen Drug Corp Div Corporate Office), NDC00173-0135-55 (Glaxo Wellcome Inc), NDC50228-0175-60 (Sciegen Pharmaceuticals Inc), NDC00173-0135-55 (Amerisourcebergen Drug Corp Dba Amerisourcebergen Drug Corp Div Corporate Office) and 2 more.
Key specifications for NDC00173-0135-55: Special Features: 150MG BUPROPION HYDROCHLORIDE PER EACH SUSTAINED RELEASE TABLET;60 PER BOTTLE; STORE IN TIGHT, LIGHT RESISTANT CONTAINER AT CONTROLLED ROOM TEMP BETWEEN 20-25 DEG C DEGC; Part Name Assigned by Controlling Agency: BUPROPION HYDROCHLORIDE SUSTAINED RELEASE TABLETS 150MG 60S; American Hospital Formulary Service Classification Number: 281604. 1 specification is documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.